AN EVALUATION OF PERIOPERATIVE CARE FOR THE OBSTRUCTIVE SLEEP APNEA PATIENT AT A LEVEL ONE TRAUMA CENTER
Doctoral Candidate Name: Precious Iriaghomo Woodward
Program: Doctor of Nursing Practice
Defense Date and Time: December 6, 2024 – 2:00 PM
Defense Location: University of North Carolina Charlotte CHHS 131.
Committee chair’s Name: Dr. Kelly Powers, PhD, RN, CNE, FNAP
Committee Members: Dr. Job Chen, PhD, Dr. Danielle Brown, DNAP, CRNA, Dr. Victoria Valencia Casales, DNP, CRNA, Dr. Michael Turner, PhD Kinesiology
Abstract:
Obstructive sleep apnea, (OSA) in the perioperative setting can result in difficult airway management and postoperative complications. It is essential that anesthetic plans are individualized and incorporate a reduction in dosages of benzodiazepines and opioids being administered. Owing to the fact that many patients with OSA are not formally diagnosed, risk identification is crucial to improving perioperative care and can be accomplished with the STOP-BANG questionnaire. The purpose of this scholarly project was to examine current perioperative care practices for benzodiazepine and opioid administration to patients with a high-risk of OSA to aid in formulating future practice recommendations. The PICOT question was: In adult patients ages 40 to 60, who underwent surgical procedures in a level one trauma center, does a STOP-BANG score ≥ 3, compared to STOP-BANG score < 3, result in a reduced dose of benzodiazepines and opioids administered perioperatively during the time period of January 2023 to June 2024?
The project took place at a level one trauma center in a major urban medical center. Data were collected via retrospective chart review. Sample size was 100 patient charts, with 50 patients having a STOP-BANG score ≥ 3 and 50 patients having a STOP-BANG score < 3. Analysis of the data included t-tests, ANOVA, and Pearson r correlations. Results concluded that the STOP-BANG group ≥ 3 received higher doses of benzodiazepines (M=1.88mg) and opioids (M=1230.11mg) than those in STOP -BANG group